SCHEMBL4688931

SCHEMBL4688931

CCCCOC(=O)NOC(=O)Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
ALDH1A1 P00352 3/20 0.49
TSHR P16473 2/20 0.49
MAPK1 P28482 2/20 0.49
CYP3A4 P08684 1/20 0.49
GLS O94925 1/20 0.48
GAA P10253 1/20 0.47
CTSK P43235 2/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
LMNA P02545 1/20 0.45
HSD17B10 Q99714 1/20 0.44
RECQL P46063 1/20 0.44
PAM P19021 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789475 0.86 TDP1 (0.54) TDP1L3MBTL1ALDH1A1TSHRMAPK1
SCHEMBL27759597 0.85 L3MBTL1 (0.50) TDP1L3MBTL1ALDH1A1TSHRMAPK1
SCHEMBL456516 0.83 ALDH1A1 (0.59) TDP1L3MBTL1ALDH1A1TSHRMAPK1
Hydrochloric Acid SCHEMBL27576461 0.82 L3MBTL1 (0.58) TDP1L3MBTL1ALDH1A1TSHRMAPK1
SCHEMBL27672935 0.82 ALDH1A1 (0.58) TDP1L3MBTL1ALDH1A1TSHRMAPK1
SCHEMBL27592314 0.80 ALDH1A1 (0.66) TDP1L3MBTL1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL27484985 0.80 ALDH1A1 (0.56) TDP1L3MBTL1ALDH1A1TSHRMAPK1
SCHEMBL750022 0.80 TSHR (0.51) TDP1L3MBTL1ALDH1A1TSHRMAPK1
SCHEMBL290979 0.80 SMN1; SMN2 (0.48) TDP1L3MBTL1ALDH1A1TSHRMAPK1
SCHEMBL7357013 0.79 TDP1 (0.58) TDP1L3MBTL1ALDH1A1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989186-A1 HYDANTOIN BASED KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2008-11-12 EP disclosed
WO-2008101840-A1 COMBINATION OF ERLOTINIB AND MEK-INHIBITORS FOR INHIBITING PROLIFERATION OF TUMOR CELLS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-28 WO disclosed
WO-2007096259-A1 HYDANTOIN BASED KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-30 WO disclosed